|
Archexin
|
DB05971 |
|
|
Acetophenone
|
DB04619 |
|
|
(9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM
|
DB04617 |
|
|
4,6-DIDEOXY-4-{[4-[(4-O-HEXOPYRANOSYLHEXOPYRANOSYL)OXY]-5,6-DIHYDROXY-3-(HYDROXYMETHYL)CYCLOHEX-2-EN-1-YL]AMINO}HEXOPYRANOSYL-(1->4)HEXOPYRANOSYL-(1->4)HEXOPYRANOSE
|
DB04618 |
|
|
(S)-tacrine(10)-hupyridone
|
DB04615 |
|
|
TACRINE(8)-4-AMINOQUINOLINE
|
DB04616 |
|
|
MDX-1303
|
DB05945 |
[MDX-1303 is a fully human antibody against the inhalation anthrax, the most lethal form of illness in humans caused by the Bacillus anthracis bacterium, and targets a protein component of these lethal toxins known as the anthrax protective antigen.] |
|
(E)-(4S,6S)-6-((S)-2-{(S)-2-[(FURAN-2-CARBONYL)-AMINO]-3-METHYL-BUTYRYLAMINO}-3-METHYL-BUTYRYLAMINO)-8-METHYL-5-OXO-4-((R)-2-OXO-PYRROLIDIN-3-YLMETHYL)-NON-2-ENOIC ACID ETHYL ESTER
|
DB04613 |
|
|
(R)-tacrine(10)-hupyridone
|
DB04614 |
|
|
Varlitinib
|
DB05944 |
[Varlitinib is an oral, selective, reversible, small molecule tyrosine kinase inhibitor of both ErbB-2 (Her-2/neu) and EGFR. Over-expression of ErbB-2 and EGFR receptors in tumors is predictive of poor prognosis in cancer patients. Varlitinib has shown significant anti-tumor activity in preclinical models of human breast, lung, and epidermal carcinoma tumors.] |
|
Resatorvid
|
DB05943 |
[Resatorvid is an investigational compound designed for the treatment of severe sepsis.] |
|
N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE
|
DB04612 |
|
|
GI-5005
|
DB05942 |
[GI-5005 is GlobeImmune's lead infectious disease product from its proprietary Tarmogen active immunotherapy platform for the treatment of chronic hepatitis C infection. GI-5005 is whole, heat-killed recombinant yeast genetically modified to express HCV-specific protein targets. Tarmogens are believed to activate both an innate immune response via Toll-like receptors (TLRs), as well as an adaptive, antigen specific cellular immune response.] |
|
Leronlimab
|
DB05941 |
[Leronlimab (PRO-140) is a humanized monoclonal antibody directed against CCR5, a portal that most forms of HIV use to enter immune system cells. Leronlimab is a viral-entry inhibitor that is designed to protect healthy cells from infection.] |
|
7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin
|
DB04610 |
|
|
Allosamidin
|
DB04628 |
[Allosamidin exhibits extremely potent inhibitory activity against chitinases from a number of sources, particularly from <i>Candida albicans</i>, and can be utilized as potent antifungal agent.] |
|
Aplyronine A
|
DB04629 |
|
|
ENMD-1198
|
DB05959 |
|
|
Apramycin
|
DB04626 |
[Apramycin is an aminoglycoside antibiotic and has a bactericidal action against many gram-negative bacteria. Apramycin is a structurally unique antibiotic that contains a bicyclic sugar moiety and a monosubstituted deoxystreptamine. It is not approved for use in humans.] |
|
Cyclouridine
|
DB04627 |
|
